Accendra Health Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Accendra Health Inc (ACH) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Accendra Health Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 49,594M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-94.9% annualized vs trailing 12 months).
- Scale: Accendra Health Inc ranks #3 of 3 companies by market capitalization in the Aluminum industry, holding 0.3% of industry market cap.
- Peer revenue share: Accendra Health Inc accounted for 100.0% of combined revenue among its tracked peer group.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
ACH Sales vs. its Competitors, Q1 2026
Accendra Health Inc generated 100.00 % of the combined sales of its peer group.
Accendra Health Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Accendra Health inc | No | No | No | Yes |
| High-Confidence Competitors (6) | ||||
| Similar-Size Competitors (2) | ||||
| Similar Growth & Profitability (1) | 100.00 % (1 of 1) | 100.00 % (1 of 1) | 100.00 % (1 of 1) | 0.00 % (0 of 1) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ACH Stock Performance relative to its Competitors
ACH Stock Performance relative to High-Confidence Competitors
ACH Stock Performance relative to Similar-Size Competitors
ACH Stock Performance relative to Similar Growth & Profitability Competitors
Accendra Health Inc's Comment on Competition and Industry Peers
Accendra Health Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Cardinal Health | Named by the company | 85% |
| Viemed Healthcare, Inc. | Named by the company | 85% |
| Quipt Home Medical | Named by the company | 85% |
| CVS Health Corporation | Named by the company | 85% |
| Lincare | Named by the company | 85% |
| AdaptHealth Corp. | Named by the company | 85% |
| Rotech | Named by the company | 85% |
| Inogen | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Accendra Health Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.